HSBC Holdings
ACOR

HSBC Holdings’s Acorda Therapeutics ACOR Stock Holding History

HSBC Holdings’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-255
Closed -$88K – 3238
2019
Q3 		$88K Buy
+255
New +$139K ﹤0.01% 2991
2014
Q3 		– Sell
-61
Closed -$248K – 1814
2014
Q2 		$248K Buy
61
+4
+7% +$16.3K ﹤0.01% 1646
2014
Q1 		$257K Buy
+57
New +$230K ﹤0.01% 1569
2013
Q4 		– Sell
-52
Closed -$213K – 1738
2013
Q3 		$213K Buy
52
+1
+2% +$4.31K ﹤0.01% 1576
2013
Q2 		$203K Buy
+51
New +$210K ﹤0.01% 1435

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

HSBC Holdings's ACOR Position: Q4 2019 in Review

HSBC Holdings sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 255 shares — an estimated $88K sold.

HSBC Holdings first reported a position in ACOR in Q2 2013 and held it in 5 quarters. The position peaked at $257K in Q1 2014. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • HSBC Holdings reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • HSBC Holdings sold 255 Acorda Therapeutics shares in Q4 2019, an estimated $88K.
  • HSBC Holdings first reported a position in Acorda Therapeutics in Q2 2013 and held it in 5 quarters.
  • HSBC Holdings's Acorda Therapeutics position peaked at $257K in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on HSBC Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.